Jefferies Group LLC Amylyx Pharmaceuticals, Inc. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
A detailed history of Jefferies Group LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 2,791 shares of AMLX stock, worth $10,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,791
Previous 50,000
94.42%
Holding current value
$10,801
Previous $963,000
92.0%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
142Shares Held
49.1MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$26.2 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$18 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$10.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$9.39 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $227M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...